MedTrace Logo

Screening for Depression and Anxiety in Patients With Heart Disease

NCT03203395 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 232

Last updated 2019-12-04

No results posted yet for this study

Summary

Depression is a risk factor for morbidity and mortality in patients with heart disease, and has a negative impact on quality of life, work capacity and treatment adherence. Screening for depression among heart patients are therefore recommended by the Norwegian Health Authorities. Also, symptoms of anxiety may negatively affect rehabilitation due to e.g. fear of physical activity and excessive worry. Patients currently receiving treatment for heart disease at Diakonhjemmet Hospital will be screened for symptoms of depression and anxiety. If such symptoms are detected, patients will be offered a counselling session with a clinical psychologist. Further, routines for collaborative communication between clinical psychologist, cardiologist and the patient's general physician will be emphasized.

Conditions

  • Depression
  • Depressive Symptoms
  • Depressive Disorder
  • Anxiety
  • Anxiety Disorders
  • Panic Attacks
  • Heart Diseases
  • Collaboration

Interventions

BEHAVIORAL

Screening and counselling

Screening for symptoms of depression and anxiety in heart patients, giving advice for prevention and managing of such symptoms and stimulating collaborative care between the hospital and the general practitioner.

Sponsors & Collaborators

  • Extrastiftelsen

    collaborator OTHER

  • LHL - The Norwegian Heart and Lung Patient Organization

    collaborator UNKNOWN

  • Diakonhjemmet Hospital

    lead OTHER

Principal Investigators

  • Torkil Berge, Psychologist · Department of Psychiatry, Diakonhjemmet Hospital, Oslo, Norway

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-10-01
Completion
2017-10-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03203395 on ClinicalTrials.gov